The Pharmacology of Longevity: Peptide Edition (Part 1) The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York The Peptide Boom Is Getting Out of Hand The Atlantic Peptides Might Be Making a Comeback In 2023, the FDA restricted 19 peptides from compounding pharmacies. Now, regulators are reviewing a possible reversal, which could allow 14 of those peptides to Ozempic Knock Offs Contain Unsafe Substance Banned by FDA, Novo Finds Bloomberg Orthopedic Use of BPC 157 Sports Med Review